[Correlation between PAFAH1B3 Expression Level and Risk of Disease Progression After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients] [0.03%]
PAFAH1B3表达量与自体造血干细胞移植后多发性骨髓瘤患者疾病进展风险的相关性研究
Zhe-Yun Gu,Jian Tao,Yi-Feng Cai et al.
Zhe-Yun Gu et al.
Objective: To investigate the association between the expression level of platelet-activating factor acetylhydrolase 1B3 (PAFAH1B3 ) gene in bone marrow CD138+ cells of patients with multiple myeloma (MM) treated with aut...
[Effects of Decitabine Combined with Anlotinib on Proliferation and Apoptosis of Multiple Myeloma Cells] [0.03%]
地西他滨联合安罗替尼对多发性骨髓瘤细胞增殖及凋亡的影响
Yang Cao,Yue Liu,Yan Liu et al.
Yang Cao et al.
Objective: To investigate the biological effects and its relative mechanism of decitabine combined with anlotinib on multiple myeloma cells. Methods: ...
[Effect of P-coumaric Acid on Apoptosis of Multiple Myeloma Cells Based on Oxidative Stress] [0.03%]
茋类茋茋茋张苠锋:阿魏酸通过氧化应激诱导多发性骨髓瘤细胞凋亡的作用研究
Zhu-Fa Hou,Bing-Jie Zhao,Song-Shan Liu et al.
Zhu-Fa Hou et al.
Objective: To investigate the effect of p-coumaric acid on apoptosis of multiple myeloma cells and its related mechanism. Methods: Mult...
[Clinical Features and Prognosis of Multiple Myeloma Patients with Secondary Primary Malignancies] [0.03%]
多发性骨髓瘤合并继发性原发恶性肿瘤患者的临床特点及预后分析
Ling-Ling Li,Meng-Lin Li,Yu Zhang et al.
Ling-Ling Li et al.
Objective: To explore the clinical characteristics and prognosis of multiple myeloma(MM) patients with secondary primary malignancies. Methods: ...
Randomized Controlled Trial
Zhongguo shi yan xue ye xue za zhi. 2023 Apr;31(2):429-434. DOI:10.19746/j.cnki.issn.1009-2137.2023.02.017 2023
[Clinical Characteristics and Nomogram Model of Nosocomial Infection in Patients with Newly Diagnosed Multiple Myeloma] [0.03%]
[新诊断多发性骨髓瘤患者医院感染的临床特征及列线图模型预测]
Xin-Yi Lu,Qiong Yao,Li-Ping Yang et al.
Xin-Yi Lu et al.
Objective: To explore the clinical characteristics of nosocomial infection in newly diagnosed multiple myeloma(NDMM) patients, and establish a predictive nomogram model. ...
[Omics Analysis of Ferroptosis and Establishment of Prognostic Model for multiple myeloma Patients] [0.03%]
铁死亡的组学分析及多发性骨髓瘤患者预后模型的建立
Zi-Ning Wang,Hao-Ran Chen,Jun-Dong Zhang et al.
Zi-Ning Wang et al.
Objective: To explore the role of ferroptosis-related genes in multiple myeloma(MM) through TCGA database and FerrDb, and build a prognostic model of ferroptosis-related genes for MM patients. ...
[Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing] [0.03%]
基于下一代测序的弥漫大B细胞淋巴瘤年轻患者突变谱及预后分析
Li-Yang Lyu,Yu-Ling Nie,Abulaiti Renaguli et al.
Li-Yang Lyu et al.
Objective: To investigate the mutational spectrum in young patients with diffuse large B-cell lymphoma (DLBCL) based on next generation sequencing (NGS), and to provide a basis for in-depth understanding of the molecular ...
Xin-Yue Ji,Da-Peng Sheng,Yu-Qiong Yang et al.
Xin-Yue Ji et al.
Objective: To investigate the clinical characteristics, diagnosis, and treatment of one patient with primary adrenal natural killer/T-cell lymphoma (PANKTCL), and to strengthen the understanding of this rare type of lymph...
[The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017] [0.03%]
[中国单中心血液系统恶性肿瘤患者多原发癌的风险及生存回顾性研究：2009至2017年]
Xu-Chang Zhang,Lei Fan,Hua Lu et al.
Xu-Chang Zhang et al.
Objective: To explore the risk and location of multiple malignancies in patients with hematologic malignancies who were followed up for 9 years in Jiangsu Province Hospital and to evaluate the impact of the second primary...
[Hematological Neoplasms Secondary to Malignant Solid Tumors with Radiotherapy and Chemotherapy: a Clinical and Prognostic Analysis] [0.03%]
恶性实体肿瘤放化疗后继发血液系统肿瘤的临床与预后分析
Juan Ren,Lin-Na Lu,Gang Wang et al.
Juan Ren et al.
Objective: To explore the clinical characteristics, treatment and prognosis of therapy-related hematological neoplasms patients secondary to malignant solid tumors. ...